CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2022; 43(01): 060-067
DOI: 10.1055/s-0042-1742703
Original Article

Determinants of Compliance for Breast and Cervical Cancers Screening among Female Police Personnel of Mumbai, India—A Cross-Sectional Study

1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
2   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
3   Department of Gynecology Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations
Funding This study is supported by Tata Trusts and Tata Memorial Hospital.

Abstract

Introduction Women working in police force have unique and vital role to play in law enforcement. Although these women have established a secured place for themselves in the police force, they are exposed to several behavioral and health risks apart from job stress. All these can have potentially serious consequences on their well-being.

Objectives To determine the compliance to breast and uterine cervical cancers screening and identify predictors of participation in breast and cervical cancers screening among women police personnel.

Materials and Methods This is a cross-sectional study conducted among the Mumbai police personnel during the period 2019 to 2021. All women working for Mumbai police work force in 12 zones were invited to participate in the study. Temporary clinics for screening were set up in different police stations and eligible participants were enrolled after obtaining written informed consent. This was followed by sociodemographic and risk factor assessment, health education program, screening for common cancers conducted by trained primary health workers (breast by clinical breast examination and uterine cervix by visual inspection with 5% acetic acid). Screen positives were referred according to predefined referral criteria for further investigations and management.

Results A total of 3,017 police women were contacted, among them, 2,629 (87.14%) were eligible for screening, 2,609 (99.24%) participated in health education, and 1,839 (69.95%) complied for breast or cervical cancer screening. Further, compliance for screening of breast and uterine cervix were 1,837 (91.67%) and 1,297 (64.72%). A total of 256 (13.94%) and 217 (11.81%) police women were screen positives for breast and cervical cancers. According to multivariate logistic regression analysis, women younger than 50 years, those who were not married or were widowed or separated, postmenopausal women, and those who did not have shift duties had higher compliance for breast and cervix cancers screening.

Conclusion Good participation for breast and cervical cancers screening was seen among the women police personnel. This study has demonstrated that awareness and screening by simple low-cost methods for breast and cervical cancers screening is easily implementable and can be replicated among the women police force in different states of India.

Note

This work is attributed to the Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Hospital, Homi Bhabha National Institute, E. Borges Marg, Parel, Mumbai 400012, Maharashtra, India.


Presentations at a Meeting

This work has been presented at the OCCUCON 2019 conference held at Rajkot, Gujarat in January 2019 and the OCCUCON 2020 conference held at Mumbai during January 2020, and the abstracts were published as Abstracts 29 & 50: OCCUCON Abstracts. Indian J Occup Environ Med 2020;24(Suppl S1):21–41. It has also been presented in the Public Health Conference 2021.


Supplementary Material



Publication History

Article published online:
23 February 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
  • 2 US Preventive Task Force recommendation. Accessed September 5, 2021 at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
  • 3 Mittra I, Mishra GA, Dikshit RP. et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ 2021; 372: n256
  • 4 Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health 2014; 80 (05) 412-417
  • 5 Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007; 18 (07) 1172-1176
  • 6 Sankaranarayanan R, Ramadas K, Thara S. et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011; 103 (19) 1476-1480
  • 7 US Preventive Task Force recommendation. Accessed September 5, 2021 at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screenings
  • 8 Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013; 2 (01) 35
  • 9 Shastri SS, Mittra I, Mishra GA. et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 2014; 106 (03) dju009
  • 10 Mona GG, Chimbari MJ, Hongoro C. A systematic review on occupational hazards, injuries and diseases among police officers worldwide: policy implications for the South African Police Service. J Occup Med Toxicol 2019; 14 (01) 2
  • 11 Merdiemah GE. Breast Cancer Screening among Female Personnel of the Ghana Armed Forces, Accra (PHD dissertation, University of Ghana).
  • 12 Naicker K, Hawes R. Cervical cancer screening in the Canadian armed forces: an estimation of screening participation rates using the CF-HERO surveillance system. Cancer Epidemiol 2020; 65: 101670
  • 13 WHO factsheet on NCDs [Internet]. [Cited September 18, 2018]. Accessed August 6, 2021 at: http://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  • 14 Basset AA. Physical examination of the breast and breast self-examination. In: Miller AB. ed. Screening for Cancer. Orlando: Academic Press; 1985
  • 15 Sankaranarayan R, Wesley R. A Practical Manual on Visual Screening for Cervical Neoplasia. IARC Technical Publication No. 41. Lyon: IARC Press; 2003
  • 16 Braun LA, Kennedy HP, Sadler LS, Dixon J, Womack J, Wilson C. US Navy women's experience of an abnormal cervical cancer screening. J Midwifery Womens Health 2016; 61 (02) 249-256
  • 17 Frommelt RA, Peterson MR, O'Leary TJ. A comparison of cervical pathology between United States Air Force women who did and did not serve in the Persian Gulf War. Ann Epidemiol 2000; 10 (05) 285-292
  • 18 Dinshaw K, Mishra G, Shastri S. et al. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. Oncology 2007; 73 (3–4): 145-153
  • 19 Allen JD, Stoddard AM, Mays J, Sorensen G. Promoting breast and cervical cancer screening at the workplace: results from the Woman to Woman Study. Am J Public Health 2001; 91 (04) 584-590
  • 20 Amin A, Shriver CD, Henry LR, Lenington S, Peoples GE, Stojadinovic A. Breast cancer screening compliance among young women in a free access healthcare system. J Surg Oncol 2008; 97 (01) 20-24
  • 21 Kulkarni SV, Mishra GA, Dusane RR. Determinants of compliance to breast cancer screening and referral in low socio-economic regions of urban India. Int J Prev Med 2019; 10: 84
  • 22 Shui Y, Xu D, Liu Y, Liu S. Work-family balance and the subjective well-being of rural women in Sichuan, China. BMC women's health 2020; 20 (01) 1
  • 23 Lairson DR, Chan W, Newmark GR. Determinants of the demand for breast cancer screening among women veterans in the United States. Soc Sci Med 2005; 61 (07) 1608-1617
  • 24 Natale K, Howard RS, Crothers BA. To Screen or Not to Screen: Presence of High-Grade Squamous Intraepithelial Lesions or Worse in a Regional Military/Beneficiary Population Under 21 Years of Age. J Am Soc Cytopathol 2013; 1 (02) S39-40
  • 25 Braun LA, Kostas-Polston EA, Miedema J, Hoffecker L, Wilson C. A scoping review of cervical cancer risk factors, prevention, diagnosis, and treatment in U.S. Active Duty Military Women. Womens Health Issues 2021; 31 (Suppl. 01) S53-S65
  • 26 Thomson BA, Nielsen PE. Women's health care in Operation Iraqi Freedom: a survey of camps with echelon I or II facilities. Mil Med 2006; 171 (03) 216-219